Acute myeloid leukemia m4e0 is an acute granulomonocytic leukemia with a cure rate of about 50%. Acute myeloid leukemia m4e0 is divided into low-risk and high-risk types according to genotyping. 1. Low-risk patients can be treated with anthracycline drugs combined with cytarabine for induction therapy, and cytarabine for consolidation therapy after achieving complete remission, and the overall treatment for about half a year can achieve a 50% cure rate. 2. High-risk patients must adopt hematopoietic stem cell transplantation to consolidate treatment after achieving complete remission with induction therapy, which has a cure rate of 30%~50%. If diagnosed with acute myeloid leukemia m4e0, it is recommended that timely hospital consultation, standardized treatment under the guidance of doctors to reduce the adverse effects of the disease.